RESEARCH: Prenatal diagnosis and management of congenital diaphragmatic hernia.

 2019 Jan 5. pii: S1521-6934(18)30263-3. doi: 10.1016/j.bpobgyn.2018.12.010. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/30772144

Prenatal diagnosis and management of congenital diaphragmatic hernia.

Congenital diaphragmatic hernia is characterized by failed closure of the diaphragm, thereby allowing abdominal viscera to herniate into the thoracic cavity and subsequently interfering with normal lung development. At birth, pulmonary hypoplasia leads to respiratory insufficiency and persistent pulmonary hypertension (PHT), that is lethal in up to 32% of patients. In isolated cases, the outcome may be predicted prenatally by medical imaging and advanced genetic testing. In those fetuses with a predicted poor outcome, fetoscopic endoluminal tracheal occlusion may be offered. This procedure is currently being evaluated in a global randomized clinical trial (www.TOTALtrial.eu). We are currently investigating alternative strategies including transplacental sildenafil administration to reduce the occurrence of persistent PHT.

KEYWORDS:

Congenital diaphragmatic hernia; Prenatal prediction; Prenatal therapy; Pulmonary hypoplasia; Sildenafil

PMID: 30772144
DOI: 10.1016/j.bpobgyn.2018.12.010

Recommended Articles

Translate »